The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This study allows head and neck cancer surgeons to specifically visualize cancerous cells
apart from normal healthy tissue. 5-aminolevulinic acid (5-ALA) is a safe and effective
FDA-approved agent successfully used by neurosurgeons for FGS of different brain tumors is
given to the patients preoperatively. Using specific wavelengths of light as well as
specialized magnified lenses the surgeons use this technique to assist in tumor resection.